In Autumn 2015 BMC supported Helix Polska in grant application for 1/1.1.1/2015 (“Fast track”) program by The National Centre for Research and Development, for the project “Development of a new, effective and highly specific therapy for breast cancer, with low toxicity profile, based on patented DOS47 technology platform, modifying tumor’s microenvironment and antitumor immune response… Read more »